Dear Colleague,
GTC is delighted to present the 2nd Allergy & Respiratory Drug Discovery
Conference, to be held on January 31 - February 1, 2013. The
conference will bring together industry, academia and government experts in the
field of allergy, asthma and COPD. Experts will facilitate discourse on the
challenges and opportunities for therapeutic and drug development for allergic
diseases for the current and future generations. Topics will range from basic
scientific research to biomarkers and clinical development. Novel immune
targets, new therapeutic interventions, genetics, epigenetics and biomarkers in
allergic diseases will be presented. Below is a list of sessions and topics that
are planned for the conference:
Novel Immune Targets in
Allergy
- IL-33 as a potential target
- IgE Antibodies to
Galactose-alpha-1, 3-galactose (alpha-gal)
- Eosinophils
- Dectin-2
- The role of Th-17
New Therapeutic Interventions
for Allergic Diseases
- IgE targeted therapeutics
- Vaccination approaches for
asthma and allergic diseases
- Inhaled biologics
- Immunotherapy
- Dietary polyphenols
- Anti-histamines
Genetic, Epigenetic &
Environmental Factors of Atopic Diseases
- Innate immunology
- Microbial stimuli/ commensal
bacteria (the microbiome)
- Epigenetics in allergic
diseases
- Genetics in asthma
- Hygiene Hypothesis
Biomarkers and Clinical
Development in Allergic Diseases
- Translation into the clinic
- Periostin as a diagnostic
- Basophils as markers
- Mast Cells
- Personalized Healthcare
This conference is also part of the
2nd
Novel Immunotherapeutics Summit, which consists of three other concurrent
conferences. In addition, an optional workshop will be held on January
30, 2013.
2nd
Novel Immunotherapeutics Summit:
Workshop:
Immune Responses in Tumor Microenvironment
Track: 2nd Allergy & Respiratory Drug Discovery
Track:
5th Immunotherapeutics & Immunomonitoring
Track:
11th Cytokines & Inflammation
Track:
Immunogenicity & Immunotoxicity
Sign up for the Summit Pass to
have access to all tracks of the summit!
Call for Papers!
To be considered for an oral presentation, please submit an abstract
here by December 31, 2012. Selected presentations will be based on quality
of abstract and availability. Presentation slots fill up fast so please submit
your abstract ASAP.
Sponsorship and exhibiting opportunities are available in a range of levels,
which can be tailored to fit your needs. Please contact 626-256-6405 x102 or
spex@gtcbio.com
for more information.
Best Regards,
Organizing
Committee
See you in San Diego!
|
